BDP1 and inflammatory breast carcinoma: BDP1 mRNA expression is significantly decreased (−1.110-fold change, p = 4.81 × 10−7) in patients with recurring IBC at three years, as shown in Figure 3B. Next, we looked at BDP1 alterations and survival at three and five years.